CCA
ABBV icon

Criterion Capital Advisors’s AbbVie ABBV Stock Holding History

Criterion Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$2.76M Hold
16,108
– – 1.74% 13
2024
Q3 		$2.76M Hold
16,108
– – 1.74% 13
2024
Q2 		$2.76M Buy
16,108
+196
+1% +$32.5K 1.74% 13
2024
Q1 		$2.9M Sell
15,912
-650
-4% -$112K 1.93% 12
2023
Q4 		$2.57M Buy
+16,562
New +$2.41M 1.86% 12

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Criterion Capital Advisors's ABBV Position: Q4 2024 in Review

Criterion Capital Advisors held its AbbVie (ABBV) position steady in Q4 2024 at 16,108 shares worth $2.76M. The position accounts for 1.74% of the portfolio, ranked #13.

Criterion Capital Advisors first reported a position in ABBV in Q4 2023 and has held it in 5 quarters since. The position peaked at $2.9M in Q1 2024. 3,744 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.

  • Criterion Capital Advisors held 16,108 shares of AbbVie worth $2.76M as of Q4 2024.
  • Criterion Capital Advisors left its AbbVie share count unchanged in Q4 2024.
  • AbbVie made up 1.74% of Criterion Capital Advisors's portfolio in Q4 2024, its #13 holding.
  • Criterion Capital Advisors first reported a position in AbbVie in Q4 2023 and has held it in 5 quarters since.
  • Criterion Capital Advisors's AbbVie position peaked at $2.9M in Q1 2024.
  • 3,744 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.

Based on Criterion Capital Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.